The Use of Measure Yourself Medical Outcome Profile (MYMOP): A Scoping Review

Patient involvement in treatment is linked to higher patient safety, quality improvement, and satisfaction. This can be
achieved through e.g., symptom management tools like the validated Measure Yourself Medical Outcome Profile (MYMOP).
There is currently no overview of its use in different healthcare settings and patients. The aim of this scoping review was to explore
and summarize how MYMOP has been used for different patient groups in different healthcare professional settings. This
scoping review was reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis for scoping reviews
(PRISMA-ScR). A systematic search was conducted in several databases and trial registers in September 2023. Screening
was conducted independently by at least two reviewers. Charting was done using predefined data categories. A protocol was uploaded
to the Open Science Framework before data charting. A total of 318 reports were included. The use of MYMOP has increased
steadily. MYMOP was mostly used in English-speaking countries (78%) and for evaluating interventions within complementary medicine (72%). Half of the studies took place in a secondary or primary healthcare setting. MYMOP was used in a broad group of patients with several symptoms and diseases, especially musculoskeletal (23%), psychological (17%), and painrelated symptoms (16%). The use of MYMOP was steadily increasing. It was mostly used within
omplementary medicine, but the use was increasing within both complementary and conventional medicine. It was mostly applied in a secondary or primary healthcare setting for patients with musculoskeletal, psychological, or pain-related symptoms and diseases. Keywords: MYMOP; MYMOP2; Symptom measures; Patient outcome assessment; Patient involvement; Scoping review.